The therapy of idiopathic pulmonary fibrosis: what is next?
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung disease, characterised by progressive scarring of the lung and associated with a high burden of disease and early death. The pathophysiological understanding, clinical diagnostics and therapy of IPF have signi...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 30, 2019
|
| In: |
European respiratory review
Year: 2019, Jahrgang: 28, Heft: 153, Pages: 1-20 |
| ISSN: | 1600-0617 |
| DOI: | 10.1183/16000617.0021-2019 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1183/16000617.0021-2019 Verlag: https://err.ersjournals.com/content/28/153/190021 
|
| Verfasserangaben: | Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, Nicolas Kahn, Veronika Müller and Michael Kreuter |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1689960574 | ||
| 003 | DE-627 | ||
| 005 | 20231207092529.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200213s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1183/16000617.0021-2019 |2 doi | |
| 035 | |a (DE-627)1689960574 | ||
| 035 | |a (DE-599)KXP1689960574 | ||
| 035 | |a (OCoLC)1341305140 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Somogyi, Vivien |e VerfasserIn |0 (DE-588)1204579180 |0 (DE-627)1689958413 |4 aut | |
| 245 | 1 | 4 | |a The therapy of idiopathic pulmonary fibrosis |b what is next? |c Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, Nicolas Kahn, Veronika Müller and Michael Kreuter |
| 264 | 1 | |c September 30, 2019 | |
| 300 | |a 20 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.02.2020 | ||
| 520 | |a Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung disease, characterised by progressive scarring of the lung and associated with a high burden of disease and early death. The pathophysiological understanding, clinical diagnostics and therapy of IPF have significantly evolved in recent years. While the recent introduction of the two antifibrotic drugs pirfenidone and nintedanib led to a significant reduction in lung function decline, there is still no cure for IPF; thus, new therapeutic approaches are needed. Currently, several clinical phase I–III trials are focusing on novel therapeutic targets. Furthermore, new approaches in nonpharmacological treatments in palliative care, pulmonary rehabilitation, lung transplantation, management of comorbidities and acute exacerbations aim to improve symptom control and quality of life. Here we summarise new therapeutic attempts and potential future approaches to treat this devastating disease. - Tweetable abstract ERSpublications - click to tweetThere is still no cure for IPF. Clinical trials focus on new therapeutic targets, improvements in nonpharmacological therapies and treatment of comorbidities and acute exacerbations. All future therapies should aim to reduce the burden of disease. http://bit.ly/2XdxqAP | ||
| 700 | 1 | |a Chaudhuri, Nazia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Torrisi, Sebastiano Emanuele |e VerfasserIn |0 (DE-588)1190667231 |0 (DE-627)1669225615 |4 aut | |
| 700 | 1 | |a Kahn, Nicolas |d 1982- |e VerfasserIn |0 (DE-588)1023650371 |0 (DE-627)718423941 |0 (DE-576)367217635 |4 aut | |
| 700 | 1 | |a Müller, Veronika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kreuter, Michael |d 1972- |e VerfasserIn |0 (DE-588)122645995 |0 (DE-627)082066795 |0 (DE-576)293362742 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European respiratory review |d Sheffield : Soc., 2005 |g 28(2019), 153, Artikel-ID 190021, Seite 1-20 |h Online-Ressource |w (DE-627)500021430 |w (DE-600)2202947-3 |w (DE-576)281286477 |x 1600-0617 |7 nnas |a The therapy of idiopathic pulmonary fibrosis what is next? |
| 773 | 1 | 8 | |g volume:28 |g year:2019 |g number:153 |g elocationid:190021 |g pages:1-20 |g extent:20 |a The therapy of idiopathic pulmonary fibrosis what is next? |
| 856 | 4 | 0 | |u https://doi.org/10.1183/16000617.0021-2019 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://err.ersjournals.com/content/28/153/190021 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20200213 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 122645995 |a Kreuter, Michael |m 122645995:Kreuter, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PK122645995 |e 950000PK122645995 |e 950900PK122645995 |e 50000PK122645995 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 6 |y j | ||
| 998 | |g 1023650371 |a Kahn, Nicolas |m 1023650371:Kahn, Nicolas |d 910000 |d 950000 |d 950900 |e 910000PK1023650371 |e 950000PK1023650371 |e 950900PK1023650371 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 4 | ||
| 998 | |g 1190667231 |a Torrisi, Sebastiano Emanuele |m 1190667231:Torrisi, Sebastiano Emanuele |d 910000 |d 950000 |d 950900 |e 910000PT1190667231 |e 950000PT1190667231 |e 950900PT1190667231 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 3 | ||
| 998 | |g 1204579180 |a Somogyi, Vivien |m 1204579180:Somogyi, Vivien |d 910000 |d 950000 |d 950900 |e 910000PS1204579180 |e 950000PS1204579180 |e 950900PS1204579180 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 1 |x j | ||
| 999 | |a KXP-PPN1689960574 |e 3594758532 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1689960574","note":["Gesehen am 13.02.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"The therapy of idiopathic pulmonary fibrosis","title_sort":"therapy of idiopathic pulmonary fibrosis","subtitle":"what is next?"}],"language":["eng"],"person":[{"family":"Somogyi","display":"Somogyi, Vivien","roleDisplay":"VerfasserIn","role":"aut","given":"Vivien"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Nazia","display":"Chaudhuri, Nazia","family":"Chaudhuri"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Sebastiano Emanuele","display":"Torrisi, Sebastiano Emanuele","family":"Torrisi"},{"family":"Kahn","display":"Kahn, Nicolas","given":"Nicolas","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Müller, Veronika","role":"aut","roleDisplay":"VerfasserIn","given":"Veronika","family":"Müller"},{"family":"Kreuter","given":"Michael","role":"aut","roleDisplay":"VerfasserIn","display":"Kreuter, Michael"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Sheffield","dateIssuedKey":"2005","publisher":"Soc.","dateIssuedDisp":"2005-"}],"name":{"displayForm":["European Respiratory Society"]},"disp":"The therapy of idiopathic pulmonary fibrosis what is next?European respiratory review","language":["eng"],"title":[{"title":"European respiratory review","title_sort":"European respiratory review"}],"pubHistory":["Nachgewiesen 14.2005 - ; auch mit durchgehender Nr.-Zählung"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 31.10.24"],"recId":"500021430","part":{"issue":"153","volume":"28","pages":"1-20","year":"2019","extent":"20","text":"28(2019), 153, Artikel-ID 190021, Seite 1-20"},"id":{"issn":["1600-0617"],"eki":["500021430"],"zdb":["2202947-3"]},"corporate":[{"display":"European Respiratory Society","roleDisplay":"Herausgebendes Organ","role":"isb"}]}],"name":{"displayForm":["Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, Nicolas Kahn, Veronika Müller and Michael Kreuter"]},"origin":[{"dateIssuedDisp":"September 30, 2019","dateIssuedKey":"2019"}],"id":{"doi":["10.1183/16000617.0021-2019"],"eki":["1689960574"]},"physDesc":[{"extent":"20 S."}]} | ||
| SRT | |a SOMOGYIVIVTHERAPYOFI3020 | ||